Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials-Reference-Cited by-同舟云学术

Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials

Published:2022-04 Issue:4 Volume:4 Page:e282-e292
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Morand Eric F,Furie Richard A,Bruce Ian N,Vital Edward M,Dall'Era Maria,Maho Emmanuelle,Pineda Lilia,Tummala Raj

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference28 articles.

1. Systemic lupus erythematosus;Kaul;Nat Rev Dis Primers,2016

2. The incidence and prevalence of systemic lupus erythematosus, 2002–2004: The Georgia Lupus Registry;Lim;Arthritis Rheumatol,2014

3. Understanding the epidemiology and progression of systemic lupus erythematosus;Pons-Estel;Semin Arthritis Rheum,2010

4. Cutaneous lupus erythematosus;McCauliffe;Semin Cutan Med Surg,2001

5. Cutaneous manifestations of systemic lupus erythematosus;Uva;Autoimmune Dis,2012

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoklonale Antikörper für entzündliche, autoimmune und onkologische Hauterkrankungen;Die Dermatologie;2024-09-13

2. Severity Scores for Cutaneous Lupus Erythematosus;Journal of Investigative Dermatology;2024-09

3. Innovations in Cutaneous Lupus;Dermatologic Clinics;2024-09

4. Screening for autoimmune diseases in apparently healthy antinuclear antibody positive individuals;Frontiers in Medicine;2024-08-20

5. Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients;Lupus;2024-08-04